XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

0
Player Avatar portefeuille (99.75) Submitted: 7/7/2010 12:12:23 PM : Outperform Start Price: $6.55 XNPT Score: -29.89

currently my fourth-largest position (see this post -> http://caps.fool.com/Blogs/biopharmaceuticals-xnpt/416742).

Report this Post 2 Comments
Member Avatar portefeuille (99.75) Submitted: 11/25/2010 2:33:38 PM
Recs: 0

http://caps.fool.com/Blogs/biopharmaceuticals-xnpt/416742.

currently 300 shares in my portfolio.

Report this Post
Member Avatar portefeuille (99.75) Submitted: 1/22/2011 6:12:52 PM
Recs: 0

I no longer update my portfolio positions.

Report this Post

Featured Broker Partners


Advertisement